Atossa Therapeutics Price Chart
Atossa Therapeutics Volume Chart
Atossa Therapeutics Market Segments
After Hours
-0.12(-2.15%)
| Open | $5.56 |
|---|---|
| Close | $5.44 |
| Low | $5.44 |
| Low Change | -0.12 (-2.15%) |
| High | $5.56 |
| High Change | +0.00 (+0.00%) |
| Range | $0.12 |
| Volume | 800 |
| Dollar Volume | $4.35K |
Regular Trading Hours
+0.35(+6.99%)
| Open | $5.01 |
|---|---|
| Close | $5.36 |
| Low | $5.00 |
| Low Change | -0.01 (-0.20%) |
| High | $5.56 |
| High Change | +0.55 (+10.98%) |
| Range | $0.56 |
| Volume | 64.058K |
| Dollar Volume | $343.35K |
Premarket
-0.11(-2.15%)
| Open | $5.11 |
|---|---|
| Close | $5.00 |
| Low | $5.00 |
| Low Change | -0.11 (-2.15%) |
| High | $5.11 |
| High Change | +0.00 (+0.00%) |
| Range | $0.11 |
| Volume | 1.29K |
| Dollar Volume | $6.45K |
After Hours Yesterday
*No Trades in Segment
Regular Trading Hours Yesterday
-0.16(-3.04%)
| Open | $5.27 |
|---|---|
| Close | $5.11 |
| Low | $5.03 |
| Low Change | -0.24 (-4.55%) |
| High | $5.36 |
| High Change | +0.09 (+1.71%) |
| Range | $0.33 |
| Volume | 56.048K |
| Dollar Volume | $286.41K |
Premarket Yesterday
*No Trades in Segment
Atossa Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $5.01 |
|---|---|
| 10 Day Moving Average (SMA10) | $5.18 |
| 20 Day Moving Average (SMA20) | $5.06 |
| 50 Day Moving Average (SMA50) | $5.47 |
| 100 Day Moving Average (SMA100) | $8.16 |
| 200 Day Moving Average (SMA200) | $10.55 |
Atossa Therapeutics Statistics
| Average Volume (30 Days) | 83.61K |
|---|---|
| P/E Ratio (Current) | -1.26 |
| EPS (Current) | -$4.04 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$29.79M |
| Cash Ratio | 5.00 |
| Current Ratio | 5.51 |
| Quick Ratio | 5.14 |
| Debt to Equity | 0.00 |
| Enterprise Value | $2.71M |
| EV to EBITDA | -0.07 |
| EV to Sales | — |
| Price to Book | 1.12 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -0.73% |
| Return on Equity | -0.88% |
Atossa Therapeutics Stock Splits
There have been 3 stock splits for Atossa Therapeutics (ATOS). The last reverse stock split occured on February 2, 2026 and reduced the outstanding shares at a ratio of 15:1.
| Date | Type | Ratio |
|---|---|---|
| Feb 2, 2026 | Reverse | 15:1 |
| Apr 20, 2018 | Reverse | 12:1 |
| Aug 26, 2016 | Reverse | 15:1 |
Atossa Therapeutics Dividends
There have been no dividends for Atossa Therapeutics (ATOS).